Skip to main content
. 2017 May 11;37(3):BSR20170112. doi: 10.1042/BSR20170112

Table 3. Comparison of the rate of adverse reactions between the DVCT and control groups.

Adverse reactions Control group (n=81) DVCT group (n=93) t/χ2 P
Dizziness, palpitation, sweating, and hot flushes 3 3 1.154 0.863
Priapism 2 8 0.27 0.083
Penile subcutaneous congestion 0 23 0.018 <0.001
Foreskin hematoma 5 0 13.44 0.015
Contrast agent leakage to the skin 3 0 8.338 0.061